Skip to main content
Log in

Ca 19-9 in the monitoring of colorectal cancer after surgery

  • Letter
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American Society of Clinical Oncology. 1996. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 14:2843–2877.

    Google Scholar 

  2. Fletcher RH. 1986. Carcinoembryonic antigen. Ann Intern Med 104:66–73.

    PubMed  CAS  Google Scholar 

  3. Safi F, Beyer HG. 1993. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 17:417–424.

    PubMed  CAS  Google Scholar 

  4. Filella X, Molina R, Pique JM et al. 1994. Use of CA 19-9 in the early detection of recurrences in colorectal cancer a comparison with CEA. Tumor Biol 15:1–6.

    Article  CAS  Google Scholar 

  5. Kouri M, Pyrhonen S, Kuusela P. 1992. Elevated CA 19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol 49:78–85.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franchi, F., Pastore, C., Izzo, P. et al. Ca 19-9 in the monitoring of colorectal cancer after surgery. Med Oncol 18, 237–238 (2001). https://doi.org/10.1385/MO:18:3:237

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MO:18:3:237

Keywords

Navigation